Compare PNW & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNW | RVTY |
|---|---|---|
| Founded | 1985 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 11.6B |
| IPO Year | 1994 | 1994 |
| Metric | PNW | RVTY |
|---|---|---|
| Price | $109.37 | $113.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 16 |
| Target Price | $100.21 | ★ $109.67 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.58% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.27 | ★ 0.36 |
| Revenue | ★ $5,339,939,000.00 | $3,311,822,000.00 |
| Revenue This Year | $5.15 | $6.37 |
| Revenue Next Year | $6.89 | $5.10 |
| P/E Ratio | $404.70 | ★ $315.43 |
| Revenue Growth | ★ 4.20 | N/A |
| 52 Week Low | $85.32 | $81.22 |
| 52 Week High | $109.52 | $118.30 |
| Indicator | PNW | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 68.39 | 68.33 |
| Support Level | $86.52 | $95.31 |
| Resistance Level | N/A | $118.30 |
| Average True Range (ATR) | 1.71 | 3.88 |
| MACD | 0.49 | 1.03 |
| Stochastic Oscillator | 98.04 | 87.57 |
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.